PHF10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.150400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.534490E-02
Normal-vs-Stage2
9.358300E-04
Normal-vs-Stage3
2.055700E-03
Normal-vs-Stage4
5.061900E-02
Stage1-vs-Stage2
7.232400E-01
Stage1-vs-Stage3
1.579820E-01
Stage1-vs-Stage4
3.646600E-01
Stage2-vs-Stage3
1.384430E-03
Stage2-vs-Stage4
4.445600E-01
Stage3-vs-Stage4
1.849620E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.352800E-04
Normal-vs-AfricanAmerican
2.131600E-02
Normal-vs-Asian
3.444600E-03
Caucasian-vs-AfricanAmerican
3.726400E-01
Caucasian-vs-Asian
4.660600E-01
AfricanAmerican-vs-Asian
1.932190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.822300E-04
Normal-vs-Female
1.996280E-03
Male-vs-Female
4.336800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.031900E-02
Normal-vs-Age(41-60Yrs)
3.595200E-03
Normal-vs-Age(61-80Yrs)
4.427200E-04
Normal-vs-Age(81-100Yrs)
2.443900E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.441000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.296000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.795000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.035500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.340000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.243400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.519300E-03
Normal-vs-Daily Drinker
3.375800E-04
Normal-vs-Weekly Drinker
1.024700E-03
Normal-vs-Occasional Drinker
5.988000E-04
Normal-vs-Social Drinker
4.419500E-02
Non Drinker-vs-Daily Drinker
3.263400E-01
Non Drinker-vs-Weekly Drinker
9.635000E-01
Non Drinker-vs-Occasional Drinker
9.204200E-01
Non Drinker-vs-Social Drinker
2.140400E-01
Daily Drinker-vs-Weekly Drinker
2.823000E-01
Daily Drinker-vs-Occasional Drinker
2.216000E-01
Daily Drinker-vs-Social Drinker
2.857800E-02
Weekly Drinker-vs-Occasional Drinker
9.547000E-01
Weekly Drinker-vs-Social Drinker
2.236200E-01
Occasional Drinker-vs-Social Drinker
1.995980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.209200E-01
Normal-vs-Grade 2
6.660400E-01
Normal-vs-Grade 3
2.240200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.416800E-01
Grade 1-vs-Grade 3
2.840800E-01
Grade 1-vs-Grade 4
2.209200E-01
Grade 2-vs-Grade 3
9.099400E-01
Grade 2-vs-Grade 4
6.660400E-01
Grade 3-vs-Grade 4
2.240200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.578100E-04
Normal-vs-NonDiabetic
2.976100E-04
Diabetic-vs-NonDiabetic
5.953800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.683100E-03
Normal-vs-NoPancreatitis
3.186000E-04
Pancreatitis-vs-NoPancreatitis
8.382800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.116100E-03
Normal-vs-N1
5.815000E-04
N0-vs-N1
8.859200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.436540E-04
Normal-vs-TP53-NonMutant
1.641980E-02
TP53-Mutant-vs-TP53-NonMutant
5.078000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
